Neobe’s Co-founder and CEO Pedro Correa de Sampaio features in the latest episode of the Bio2Bedside Podcast, a live show featuring companies building innovative advanced therapies.
During the episode, Neobe’s focus on unlocking existing potentially curative technologies was explored and key points regarding our technology, a synthetic biology platform engineering microbial vectors to physically break down the dense extracellular matrix of solid tumours, was discussed. The conversation also explored the recent developments in the oncology and live biotherapeutic spaces, highlighting why it is an exciting time to be part of such a movement.
